Senescence-accelerated overexpression of S100β in brain of SAMP6 mice

Neurobiology of Aging

Volumn 19, Issue 1, 1998, Pages 71-76

  Griffin, W S T ^a,b,c   Sheng, J G ^b,d   Mrak, R E ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Immunohistochemistry; Northern analysis; S100 gene; SAMP6 mice; Senescence; Western immunoblot

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S 100;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; AUTOCRINE EFFECT; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEMISPHERE; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENESCENCE;

AGING; ANIMALS; BLOTTING, WESTERN; GLIAL FIBRILLARY ACIDIC PROTEIN; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, INBRED STRAINS; S100 PROTEINS;

EID: 0031972097     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(97)00167-X     Document Type: Article

References (29)

1. Dunn R., Landry C., O'Hanlon D., Dunn J., Allore R., Brown I., Marks A. Reduction in S100 protein beta subunit mRNA in C6 rat glioma cells following treatment with anti-microtubular drugs. J. Biol. Chem. 262:1987;3562-3566.
2. Flood J. F., Farr S. A., Kaiser F. E., Morley J. E. Age-related impairment in learning but not memory in SAMP8 female mice. Pharmacol. Biochem. Behav. 50:1995;661-664.
3. Gerlai R., Friend W., Becker L., O'Hanlon D., Marks A., Roder J. Female transgenic mice carrying multiple copies of the human gene for S100β are hyperactive. Behav. Brain Res. 55:1993;51-59.
4. Gerlai R., Marks A., Roder J. T-maze spontaneous alteration rate is decreased in S100β transgenic mice. Behav. Neurosci. 108:1994;100-106.
5. Gerlai R., Roder J. Female specific hyperactivity in S100β transgenic mice does not habituate in open-field. Behav. Brain Res. 59:1993;119-124.
6. Gerlai R., Roder J. Abnormal exploratory behavior in transgenic mice carrying multiple copies of the human gene for S100β J. Psychiatry Neurosci. 20:1995;105-112.
7. Griffin W. S. T., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., White C. L. III, Araoz C. Brain IL-1 and S100 immunoreactivity is elevated in Down Syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
8. Griffin W. S. T., Stanley L. C., Yeralan O., Rovnaghi C. R., Marshak D. R. Methods for the study of cytokines in human neurodegenerative disease. Met. Neurosci. 17:1993;268-287.
9. Griffin W. S. T., Yeralan O., Sheng J. G., Boop F. A., Mrak R. E., Rovnaghi C. R., Burnett B. A., Feoktistova A., Van Eldik L. J. Overexpression of the neurotrophic cytokine s100β in human temporal lobe epilepsy. J. Neurochem. 65:1995;228-233.
10. Hosokawa M., Kasai R., Higuchi K., Takeshita S., Shimizu K., Hamamoto H., Honma A., Irino M., Toda K., Matsumora A., Matsushita M., Takeda T. Grading score system a method for evaluation of the degree of senescence in Senescence-Accelerated Mouse (SAM) . Mech. Ageing Dev. 26:1984;91-102.
11. Janus C., Janus M., Roder J. Spatial exploration in transgenic mice expressing human β-S100. Learn. Mem. 64:1995;58-67.
12. Jilka R. L., Weinstein R. S., Takahashi K., Parfitt A. M., Manolagas S. C. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J. Clin. Invest. 97:1996;1732-1740.
13. Kato K., Suzuki F., Morishita R., Asano T., Sato T. Selective increase in S-100β protein by aging in rat cerebral cortex. J. Neurochem. 54:1990;1269-1274.
14. Kitado H., Higuchi K., Higuchi K., Takeda T. Molecular genetic characterization of the senescence-accelerated mouse (SAM) strains. J. Gerontol. Biol. Sci. 49:1994;B247-B254.
15. Kligman D., Marshak D. R. Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. USA. 82:1985;7136-7139.
16. Marshak D. R., Pesce S. A., Stanley L. C., Griffin W. S. T. Increased S100β neurotrophic activity in Alzheimer disease temporal lobe. Neurobiol. Aging. 13:1991;1-7.
17. Matsushita M., Tsuboyama T., Kasai R., Okumura H., Yamamuro T., Higuchi K., Higuchi K., Kohno A., Yonezu T., Utani A., Umezawa M., Takeda T. Age-related changes in bone mass in the senescence-accelerated mouse (SAM). SAM-R/3 and SAM-P/6 as new murine models for senile osteoporosis. Am. J. Pathol. 125:1986;276-283.
18. Mrak R. E., Sheng J. G., Griffin W. S. T. Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;273-279.
19. Ohnishi K., Tomimoto H., Akiguchi I., Seriu N., Kawamata T, Nakamura S., Kimura J., Nishio T., Higuchi K., Hosokawa M. Age-related decrease of nerve growth factor-like immunoreactivity in the basal forebrain of senescence-accelerated mice. Acta Neuropathol. (Berl). 90:1995;11-16.
20. Reeves R. G., Yao J., Crowley M. R., Buk S., Zhang X., Yarowsky P., Gearhart J. D., Hilt D. Astrocytosis and axonal proliferation in the hippocampus of S100β transgenic mice. Proc. Natl. Acad. Sci. USA. 91:1994;5359-5363.
21. Selinfreund, R. H.; Barger, S. W.; Pledger, W. J.; Van Eldik, L. J. Neurotrophic protein S100 stimulates glial cell proliferation. Proc. Natl. Acad. Sci. USA 88:3554-2028; 1991.
22. Sheng J. G., Ito K., Skinner R. D., Mrak R. E., Rovnaghi C. R., Van Eldik L. J., Griffin W. S. T. In vivo and in vitro evidence supporting a role for the inflammatory cytokine IL-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging. 17:1996;761-766.
23. Sheng J. G., Mrak R. E., Griffin W. S. T. S100β protein expression in Alzheimer disease: Potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 39:1994;398-404.
24. Sheng J. G., Mrak R. E., Rovnaghi C. R., Kozlowska E., Van Eldik L. G., Griffin W. S. T. Human brain S100β and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease. Neurobiol. Aging. 17:1996;359-363.
25. Takeda T., Hosokawa M., Higuchi K. Senescence-accelerated mouse (SAM): A novel murine model of accelerated senescence. J. Am. Geriatr. Soc. 39:1991;911-919.
26. Takeda T., Hosokawa M., Higuchi K. Senescence-Accelerated Mouse (SAM). A novel murine model of aging. Takeda T. The SAM Model of Senescence (International Congress Series 1062). 1994;15-22 Excerpta Medica, Amsterdam.
27. Takeda T., Hosokawa M., Takeshita S., Irino M., Higuchi K., Matsushita T., Tomita Y., Yasuhira K., Shimizu K., Ishii M., Yamamuro T. A new murine model of accelerated senescence. Meth. Ageing Dev. 17:1981;183-194.
28. Van Eldik L. J., Griffin W. S. T. S100β expression in Alzheimer's disease: Relation to neuropathology in brain regions. Biochim. Biophys. Acta. 1223:1994;398-403.
29. Whitaker-Azmitia, P. M.; Gerlai, M.; Wingate, Borella, A. Morphological studies of mice overexpressing the serotonergic growth factor S100β. Soc Neurosci. Abst. (Part 1) 22:606; 1996.